David Shorr was diagnosed with Alzheimer’s disease at 56. He’s one of the first in the United States to participate in a clinical trial at The Ohio State University Wexner Medical Center that uses non-invasive methods to aim low-intensity focused ultrasound to open the blood-brain barrier and deliver Alzheimer’s treatment more directly to the brain tissue.
Learn more about the clinical trial: [ Ссылка ]
Take the SAGE test to detect early signs of Alzheimer’s and Dementia. [ Ссылка ]
Visit The Ohio State University Wexner Medical Center: [ Ссылка ]
Subscribe to our YouTube channel: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
Follow us on Instagram: [ Ссылка ]
Connect with us on LinkedIn: [ Ссылка ]
